tumor-ablation-market
Published

April 2017

Tumor Ablation Market - Growth, Trends, and Forecasts (2016 - 2021)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global tumor ablation market accounted for USD 350 million in 2015 and is estimated to reach USD 406 million in 2016. The market is expected to reach USD 765 million by 2021 and is projected to grow at a CAGR of 13.5 % from 2016 to 2021.

Market Dynamics

The tumor ablation market is growing at a considerable rate owing to factors such as the increasing incidence of cancer, increasing awareness of ablation procedures, which are better than surgeries for tumors no longer than 3 cm, and increasing demand for minimally invasive cancer procedures. In addition, the rising geriatric population, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices, increase in awareness for personalized drugs, and increase in healthcare expenditure are other factors driving the market growth. However, the strict regulatory process is a restraint to the growth.

The key opportunities for the global tumor ablation market are increasing investment in R&D of novel therapies and considerable support from governments to develop the therapies. The massive untapped markets in the emerging countries are creating a lot of opportunities for the global tumor ablation market. However, the long approval time for product launches is the key challenge faced by the market.

Global Tumor Ablation Market segmentation

The global tumor ablation market is segmented by the type of technology into-

  • Radiofrequency (rf) ablation
  • Microwave ablation
  • Cryoablation
  • Other technologies

The market is segmented by the mode of treatment into-

  • Surgical ablation
  • Laparoscopic ablation
  • Percutaneous ablation

The market is segmented by the type of application into-

  • Liver cancer
  • Lung cancer
  • Kidney cancer
  • Bone metastasis
  • Other applications

The market is segmented by geography into North America, Europe, Asia-Pacific, and Rest of the World. Radiofrequency ablation holds a prominent share in its segment due to its high specificity and since it targets the tissue level without damaging the surrounding cells. Based on the mode of treatment, surgical ablation procedures have the largest share due to the increasing prevalence of liver and breast cancers, which require open surgical procedures. In the applications segment, liver cancer accounts for largest share due to the rising incidence of the bile duct and primary liver cancer. 

 

North America Ablation market share – By Technology (2016-2022)

Key Players

Some of the largest players in the tumor ablation market are:

  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • BVM Medical Limited
  • COMSOL Inc.
  • Galil Medical, Inc.
  • INTIO Inc.
  • Medtronic PLC
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • SonaCare Medical, LLC

Key Deliverables

  • Market analysis for the tumor ablation market, with region-specific assessments and competition analysis.
  • Market definition along with the identification of key drivers, restraints, opportunities, and challenges.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
  • Identification and analysis of the macro and micro factors that affect the global tumor ablation market.
  • Insights of the market in the regions that have the highest potential for growth and to also identify the markets that are still untapped.
RELATED REPORTS
No related reports available.
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?